Correction to MUC16 Is Lost from the Uterodome (Pinopode) Surface of the Receptive Human Endometrium: In Vitro Evidence That MUC16 Is a Barrier to Trophoblast Adherence [Biol Reprod 78, 1, (2008) 134-142] DOI:10.1095/biolreprod.106.058347;MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: In vitro evidence that MUC16 is a barrier to trophoblast adherence

Biology of Reproduction

Volumn 78, Issue 1, 2008, Pages 134-142

  Gipson, Ilene K ^a   Blalock, Timothy ^a   Tisdale, Ann ^a   Spurr Michaud, Sandra ^a   Allcorn, Sara ^a   Stavreus Evers, Anneli ^b   Gemzell, Kristina ^b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Female reproductive tract; Implantation; Trophoblast; Uterus

Indexed keywords

MUCIN; MUCIN 1; MUCIN 16; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ADHESION; CELL LINE; CILIATED EPITHELIUM; CONTROLLED STUDY; ENDOCYTOSIS; ENDOMETRIUM; EPITHELIUM CELL; EXOCYTOSIS; EXPERIMENT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; MEDICAL RESEARCH; MICROVILLUS; PRIORITY JOURNAL; SAMPLE; SECRETORY CELL; TROPHOBLAST; UTERUS; UTERUS BIOPSY;

EID: 38149118993     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.115741     Document Type: Erratum

References (52)

1. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 2006; 7:185-199.
2. Giudice LC. Microarray expression profiling reveals candidate genes for human uterine receptivity. Am J Pharmacogenomics 2004; 4:299-312.
3. Horcajadas JA, Riesewijk A, Dominguez F, Cervero A, Pellicer A, Simon C. Determinants of endometrial receptivity. Ann N Y Acad Sci 2004; 1034:166-175.
4. Thathiah A, Brayman M, Dharmaraj N, Julian JJ, Lagow EL, Carson DD. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology 2004; 145:4192-4203.
5. Aplin JD. Adhesion molecules in implantation. Rev Reprod 1997; 2:84-93.
6. Stavreus-Evers A, Nikas G, Sahlin L, Eriksson H, Landgren BM. Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil Steril 2001; 76:782-791.
7. Martel D. Surface changes of the luminal uterine epithelium during the human menstrual cycle, a scanning microscopic study. In: Burs J, Gantrey J (eds.), The Endometrium: Hormonal Implants. New York: Plenum; 1981:15-29.
8. Nikas G, Drakakis P, Loutradis D, Mara-Skoufari C, Koumantakis E, Michalas S, Psychoyos A. Uterine pinopodes as markers of the 'nidation window' in cycling women receiving exogenous oestradiol and progesterone. Hum Reprod 1995; 10:1208-1213.
9. Nikas G, Makrigiannakis A. Endometrial pinopodes and uterine receptivity. Ann N Y Acad Sci 2003; 997:120-123.
10. Adams SM, Gayer N, Hosie MJ, Murphy CR. Human uterodomes (pinopods) do not display pinocytotic function. Hum Reprod 2002; 17:1980-1986.
11. Murphy CR. Understanding the apical surface markers of uterine receptivity: pinopods or uterodomes? Hum Reprod 2000; 15:2451-2454.
12. Murphy CR. Uterine receptivity and the plasma membrane transformation. Cell Res 2004; 14:259-267.
13. Aplin JD, Kimber SJ. Trophoblast-uterine interactions at implantation. Reprod Biol Endocrinol 2004; 2:48-59.
14. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4:45-60.
15. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001; 6:339-353.
16. DeSouza MM, Surveyor GA, Price RE, Julian J, Kardon R, Zhou X, Gendler S, Hilkens J, Carson DD. MUC1/episialin: a critical barrier in the female reproductive tract. J Reprod Immunol 1999; 45:127-158.
17. Surveyor GA, Gendler SJ, Pemberton L, Das SK, Chakraborty I, Julian J, Pimental RA, Wegner CC, Dey SK, Carson DD. Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology 1995; 136:3639-3647.
18. Thathiah A, Blobel CP, Carson DD. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 2003; 278:3386-3394.
19. Aplin JD, Hey NA, Graham RA. Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 1998; 8:269-276.
20. Horne AW, White JO, Lalani EN, Mobberley MA, Margara RA, Trew GH, Ryder TA. Analysis of epitopes on endometrial epithelium by scanning immunoelectron microscopy. Biochem Biophys Res Commun 2002; 292:102-108.
21. Horne AW, Lalani EN, Margara RA, Ryder TA, Mobberley MA, White JO. The expression pattern of MUC1 glycoforms and other biomarkers of endometrial receptivity in fertile and infertile women. Mol Reprod Dev 2005; 72:216-229.
22. Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martin JC, Remohi J, Pellicer A, Simon C. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol Reprod 2001; 64:590-601.
23. Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 2001; 276:27371-27375.
24. O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol 2001; 22:348-366.
25. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K. Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue. Anticancer Res 2003; 23:1075-1080.
26. Jhang H, Chuang L, Visintainer P, Ramaswamy G. CA 125 levels in the preoperative assessment of advanced-stage uterine cancer. Am J Obstet Gynecol 2003; 188:1195-1197.
27. Gipson IK. Human endocervical mucins. Ernst Schering Res Found Workshop 2005:219-244.
28. Argueso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci 2003; 44:2487-2495.
29. Argueso P, Gipson IK. Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res 2001; 73:281-289.
30. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res 2004; 78:379-388.
31. Stavreus-Evers A, Mandelin E, Koistinen R, Aghajnova L, Hovatta O, Seppala M. Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B. Fertil Steril 2006; 85:1803-1811.
32. Stavreus-Evers A, Koraen L, Scott JE, Zhang P, Westlund P. Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary. Fertil Steril 2005; 83:156-162.
33. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracelllar matrix components. J Cell Biol 1995; 129:255-265.
34. Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren's syndrome. Invest Ophthalmol Vis Sci 2002; 43:1004-1011.
35. Gipson IK, Spurr-Michaud S, Argueso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003; 44:2496-2506.
36. Hori Y, Spurr-Michaud S, Russo C, Argueso P, Gipson I. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci 2004; 45:114-122.
37. Fink L, Seeger W, Ermert L, Hänze J, Stahl U, Grimminger F, Kummer W, Bohle RM. Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Med 1998; 4:1329-1333.
38. de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A, Pouillart P, Magdelenat H. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res 2000; 6:3117-3122.
39. Clarke CL, Feil PD, Satyaswaroop PG. Progesterone receptor regulation by 17 beta-estradiol in human endometrial carcinoma grown in nude mice. Endocrinology 1987; 121:1642-1648.
40. Mo B, Vendrov A, Palomino W, DuPont B, Apparao K, Lessey B. ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium. Biol Reprod 2006; 75:387-394.
41. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-553.
42. Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols. J Gene Med 1999; 1:195-209.
43. Spurr-Michaud S, Argüeso P, Gipson I. Assay of mucins in human tear fluid. Exp Eye Res 2007; 84:939-950.
44. Tsutsumida H, Swanson BJ, Singh PK, Caffrey TC, Kitajima S, Goto M, Yonezawa S, Hollingsworth MA. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res 2006; 12:2976-2987.
45. Aplin JD, Straszewski-Chavez SL, Kalionis B, Dunk C, Morrish D, Forbes K, Baczyk D, Rote N, Malassine A, Knofler M. Trophoblast differentiation: progenitor cells, fusion and migration - a workshop report. Placenta 2006; 27(Suppl A):S141-S143.
46. Kucik DF, Wu C. Cell-adhesion assays. Methods Mol Biol 2005; 294:43-54.
47. Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway KL III, Kufe D. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 2001; 276:35239-35242.
48. Gipson IK, Moccia R, Spurr-Michaud S, Argüeso P, Gargiulo AR, Hill JAI, Offner GD, Keutmann HT. The amount of MUC5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metabol 2001; 86:594-600.
49. Hey NA, Graham RA, Seif MW, Aplin JD. The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase. J Clin Endocrin Metabol 1994; 78:337-342.
50. Martinez AR, Thomas CM, Segers MF, Schoemaker J, Eskes TK. CA-125 levels in cervical mucus during the menstrual cycle. Fertil Steril 1994; 61:843-849.
51. Vujisic S, Kupesic S, Mihaljevic D, Aksamija A, Kurjak A. Evaluation of serum CA 125 concentration before and during hormonal induced cycles as predictor of IVF/ET outcome. Am J Reprod Immunol 2002; 48:355-360.
52. Hamilton JA, Iles RK, Gunn LK, Wilson CM, Lower AM, Grudzinskas JG. High concentrations of CA 125 in uterine flushings: influence of cause of infertility and menstrual cycle day. Gynecol Endocrinol 2002; 16:19-25.